Lifeward Ltd(LFWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LFWD Lifeward Ltd

Trading 01-15 11:44:42 EST

0.6689

+0.0135

+2.06%

High0.6744	Low0.6554	Vol109.45K
Open0.6670	D1 Closing0.6554	Amplitude2.90%
Mkt Cap12.24M	Tradable Cap10.32M	Total Shares18.29M
T/O72.52K	T/O Rate0.71%	Tradable Shares15.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LFWD","market":"US","secType":"STK","nameCN":"Lifeward Ltd","latestPrice":0.6689,"timestamp":1768495307988,"preClose":0.6554,"halted":0,"volume":109450,"delay":0,"floatShares":15421000,"shares":18293776,"eps":-2.91,"marketStatus":"Trading","change":0.0135,"latestTime":"01-15 11:44:42 EST","open":0.667,"high":0.6744,"low":0.6554,"amount":72516.988423,"amplitude":0.02899,"askPrice":0.6728,"askSize":200,"bidPrice":0.661,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-2.91,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1768510800000},"marketStatusCode":2,"adr":0,"listingDate":1410494400000,"exchange":"NASDAQ","adjPreClose":0.6554,"preHourTrading":{"tag":"盘前","latestPrice":0.6738,"preClose":0.6554,"latestTime":"09:29 EST","volume":3611,"amount":2419.5788241299997,"timestamp":1768487380614},"postHourTrading":{"tag":"盘后","latestPrice":0.67,"preClose":0.6554,"latestTime":"19:59 EST","volume":6699,"amount":4449.982,"timestamp":1768438772224},"volumeRatio":0.386424,"impliedVol":1.4291,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/LFWD","defaultTab":"news","newsList":[{"id":"2603642601","title":"Oramed Transfers Oral Drug Platform to Lifeward in Strategic Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2603642601","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603642601?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:32","pubTimestamp":1768426325,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals Inc. has entered into binding agreements with Lifeward Ltd. to transfer its proprietary Protein Oral Drug  delivery technology to Lifeward. As part of the transaction, Oramed will receive a 49.9% beneficial ownership interest in Lifeward, along with warrants. Oramed will continue to manage and fund the upcoming clinical trial for the oral delivery platform. In addition, Oramed will receive 4% of net sales from Lifeward’s ReWalk franchise for up to 10 years. Lifeward will issue $10 million in senior secured convertible notes, with Oramed investing $9 million, and has generated $26 million in revenue from its FDA-approved ReWalk and AlterG products in the last four quarters. The transaction is expected to advance the oral insulin program and further diversify Lifeward’s biomedical innovation portfolio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL8XQX0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4082","BK4604","LFWD","ORMP"],"gpt_icon":0},{"id":"2603868112","title":"Oramed Invests $9 Million in Lifeward and Transfers Oral Drug Delivery Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2603868112","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603868112?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:58","pubTimestamp":1768309096,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals Inc. has entered into a strategic transaction with Lifeward Ltd., transferring its proprietary Protein Oral Drug  delivery technology to Lifeward. As part of the agreement, Oramed will obtain a 49.9% beneficial ownership interest in Lifeward and will invest $9 million in a $10 million senior secured convertible note, with the potential to significantly increase its stake through additional milestone-based investments and warrant exercises. Oramed will also fund and manage an anticipated upcoming clinical trial for the technology, marking a significant expansion of its involvement in oral drug delivery innovation and medical robotics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oramed Pharmaceuticals Inc. publi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL8BZHP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORMP","BK4007","LFWD","BK4604","BK4082"],"gpt_icon":0},{"id":"2603969681","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969681","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603969681?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:55","pubTimestamp":1768308900,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nAQN2LHFAJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LFWD","BK4604"],"gpt_icon":0},{"id":"2601843316","title":"Lifeward Ltd. Held Extraordinary General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2601843316","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601843316?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:16","pubTimestamp":1767734203,"startTime":"0","endTime":"0","summary":"Lifeward Ltd. held an Extraordinary General Meeting of Shareholders on January 6, 2026. Shareholders approved authorizing the Board of Directors to determine whether to implement a reverse share split of the company’s outstanding ordinary shares and to set the split ratio within a specified range. Conditional on that approval, shareholders also approved amendments to the company’s articles of association to allow an increase in authorized share capital, should a reverse share split be effected. In addition, shareholders approved an amendment to eliminate the par value of the company’s ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDLbR5zKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFWD","BK4604","BK4082"],"gpt_icon":0},{"id":"2592384190","title":"Lifeward Names Bob Marshall as Board Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2592384190","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592384190?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:26","pubTimestamp":1766179615,"startTime":"0","endTime":"0","summary":"Lifeward  said late Friday it has named Bob Marshall as board chairman, starting Jan. 1, 2026.He succeeds Joseph Turk, who will pursue a new opportunity at Fresenius Medical Care, the company said.Marshall has been a board member and chair of its audit committee since joining in 2024, according to a statement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","LFWD","BK4604"],"gpt_icon":0},{"id":"2592919089","title":"Lifeward Appoints Bob Marshall As Chairman Of The Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2592919089","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592919089?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:22","pubTimestamp":1766179331,"startTime":"0","endTime":"0","summary":"Dec 19 (Reuters) - Lifeward Ltd <2RW.MU>::*LIFEWARD APPOINTS BOB MARSHALL AS CHAIRMAN OF THE BOARD  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 19-DEC-202521:05:00.107 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nRSD2LxwR7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LFWD","BK4604"],"gpt_icon":0},{"id":"2592454197","title":"Lifeward Ltd. Names Bob Marshall Chairman of the Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2592454197","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592454197?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:05","pubTimestamp":1766178316,"startTime":"0","endTime":"0","summary":"Lifeward Ltd. has appointed Bob Marshall as Chairman of the Board, effective January 1, 2026. He succeeds Joseph Turk, who is leaving the board for a new position at Fresenius Medical Care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via GlobeNewswire  on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL8FDFPf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014039.USD","BK4585","BK4604","SG9999014005.SGD","NDAQ","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BKPKM429.USD","BK4112","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","LFWD","BK4082","LU2210150020.SGD"],"gpt_icon":0},{"id":"2592990990","title":"Lifeward Secures International Distribution Agreement for ReWalk Exoskeleton with Verita Neuro","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990990","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592990990?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976487,"startTime":"0","endTime":"0","summary":"Lifeward Ltd. announced the expansion of patient access to its ReWalk Personal Exoskeleton through a new international distribution agreement with Verita Neuro, a company under Verita Healthcare Ltd. Under the agreement, Verita Neuro will serve as the exclusive distributor of the ReWalk exoskeleton in Mexico, Thailand, and the United Arab Emirates. The partnership is intended to integrate the ReWalk exoskeleton into Verita Neuro's treatment modalities for people with neurological and spinal cord injuries, providing in-patient training and rehabilitation to support clinical adoption in physical rehabilitation settings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL2Pmyjn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4604","IE00BKPKM429.USD","BK4585","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014021.USD","BK4082","LU2210149790.SGD","BK4588","LFWD","BK4112","SG9999014005.SGD"],"gpt_icon":0},{"id":"2584931807","title":"Lifeward Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584931807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584931807?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:29","pubTimestamp":1763465340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LFWD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 18, 2025 06:29 ET (11:29 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFWD","BK4082","BK4604"],"gpt_icon":0},{"id":"2584939767","title":"Lifeward price target lowered to $4.50 from $13 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2584939767","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584939767?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:11","pubTimestamp":1763464263,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on Lifeward (LFWD) to $4.50 from $13 and keeps a Buy rating on the s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lifeward-price-target-lowered-to-4-50-from-13-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lifeward-price-target-lowered-to-4-50-from-13-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4604","LFWD"],"gpt_icon":0},{"id":"2584625820","title":"UnitedHealthcare Medicare Advantage Plan Approves Coverage for Lifeward ReWalk 7 Exoskeleton","url":"https://stock-news.laohu8.com/highlight/detail?id=2584625820","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584625820?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:00","pubTimestamp":1763384440,"startTime":"0","endTime":"0","summary":"Lifeward Ltd. has announced that it received its first prior authorization approval from a UnitedHealthcare Medicare Advantage Plan for the ReWalk 7 Personal Exoskeleton. This marks a significant step forward in expanding reimbursement pathways and accelerating access to advanced exoskeleton technology for individuals with spinal cord injuries. The approval follows the Centers for Medicare & Medicaid Services' 2024 implementation of a reimbursement pathway for personal exoskeletons. Lifeward reports an increase in prior authorizations as more payers adopt coverage, improving predictability and access for beneficiaries. No other organizations were mentioned as recipients of this approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. L","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDLb718zN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","LU2210150020.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BGHQF748.EUR","LU2210149790.SGD","LU2095319765.USD","BK4082","BK4585","IE00BKPKM429.USD","BK4112","LFWD","BK4588","IE00B64PRP62.GBP","NDAQ"],"gpt_icon":0},{"id":"2583633634","title":"Lifeward Ltd. Earnings Call: Optimism Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2583633634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583633634?lang=en_us&edition=fundamental","pubTime":"2025-11-15 08:30","pubTimestamp":1763166631,"startTime":"0","endTime":"0","summary":"Rewalk Robotics Ltd. (($LFWD)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Lifeward Lt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lifeward-ltd-earnings-call-optimism-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lifeward-ltd-earnings-call-optimism-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFWD"],"gpt_icon":0},{"id":"2583850939","title":"Lifeward Ltd. posts Q3 revenue of $6.2 million and reports 16% decrease in cash burn","url":"https://stock-news.laohu8.com/highlight/detail?id=2583850939","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583850939?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:16","pubTimestamp":1763126188,"startTime":"0","endTime":"0","summary":"Lifeward Ltd. reported revenue of $6.2 million for the third quarter of 2025, up 1.0% from $6.1 million in the third quarter of 2024 and an 8.0% increase from $5.7 million in the second quarter of 2025. Revenue from the sale of traditional products and services, including ReWalk Personal exoskeletons and the MyoCycle FES bike, was $3.1 million, representing a 24.0% increase year-over-year, attributed to higher Medicare-related sales. The company recorded a net loss of $3.6 million, or $0.41 per share, compared to a net loss of $4.0 million, or $0.45 per share, in the same period last year. Cash used in operations decreased by 16.0% to $3.8 million from $4.5 million in the prior year quarter. As of September 30, 2025, Lifeward had $2.0 million in unrestricted cash and no debt. After the quarter ended, Lifeward entered into a $3.0 million loan agreement with Oramed Ltd. The company reaffirmed its full-year 2025 revenue guidance of $24 to $26 million and projected a non-GAAP net loss betw","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL3ZBWjG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ORMP","BK4007","LFWD","BK4604"],"gpt_icon":0},{"id":"2583501879","title":"Lifeward Ltd. Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501879","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583501879?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:00","pubTimestamp":1763125200,"startTime":"0","endTime":"0","summary":"Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established  Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27% decre","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/14/3188259/32993/en/Lifeward-Ltd-Reports-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","LFWD","BK4082"],"gpt_icon":0},{"id":"2582687361","title":"Lifeward Ltd. to Release Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582687361","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582687361?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:03","pubTimestamp":1762776180,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via GlobeNewswire  on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL9MDKn5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0314104364.USD","BK4604","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4585","BK4588","LU2095319765.USD","LU2210150020.SGD","BK4082","LFWD"],"gpt_icon":0},{"id":"2581840998","title":"Lifeward Ltd  expected to post a loss of 21 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581840998","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581840998?lang=en_us&edition=fundamental","pubTime":"2025-11-07 23:38","pubTimestamp":1762529884,"startTime":"0","endTime":"0","summary":"Lifeward Ltd  expected to post a loss of21cents a share - Earnings Preview Lifeward Ltd LFWD.OQ, LFWD.O is expected to  show a rise in quarterly revenue when it reports  results on November 10 (estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL8N3WJ26J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LFWD","BK4604"],"gpt_icon":0},{"id":"2575171050","title":"Lifeward Ltd. Reports Preliminary Q3 2025 Revenue of $6.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2575171050","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575171050?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:01","pubTimestamp":1760612518,"startTime":"0","endTime":"0","summary":"Lifeward Ltd. reported preliminary revenue of approximately $6.2 million for the quarter ended September 30, 2025. Preliminary U.S. GAAP operating expenses for the period were in the range of $5.8 million to $5.9 million. The company's cash and cash equivalents as of September 30, 2025, totaled approximately $2.0 million. These results are unaudited and subject to final review.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL8MPqXt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4604","LFWD"],"gpt_icon":0},{"id":"2570977000","title":"Even With A 27% Surge, Cautious Investors Are Not Rewarding Lifeward Ltd.'s (NASDAQ:LFWD) Performance Completely","url":"https://stock-news.laohu8.com/highlight/detail?id=2570977000","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570977000?lang=en_us&edition=fundamental","pubTime":"2025-09-25 18:41","pubTimestamp":1758796880,"startTime":"0","endTime":"0","summary":"Despite an already strong run, Lifeward Ltd. ( NASDAQ:LFWD ) shares have been powering on, with a gain of 27% in the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfwd/lifeward/news/even-with-a-27-surge-cautious-investors-are-not-rewarding-li","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfwd/lifeward/news/even-with-a-27-surge-cautious-investors-are-not-rewarding-li","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","BK4604","TSYW.SI","MNQmain","BK4082","BK4211","LFWD","PSQ","QID","QLD","SQQQ","TQQQ","USJW.SI","NVIW.SI","USAW.SI","NQmain","ISBC"],"gpt_icon":1},{"id":"1193872347","title":"Robotics Stocks Shined. Arbe Robotics Up 16%; Nauticus Robotics Up 10%; Richtech Robotics Up 5%; Symbotic And GuardForce Up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193872347","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193872347?lang=en_us&edition=fundamental","pubTime":"2025-09-22 21:52","pubTimestamp":1758549168,"startTime":"0","endTime":"0","summary":"Robotics Stocks Shined. Arbe Robotics up 16%; Nauticus Robotics up 10%; Richtech Robotics up 5%; Symbotic and GuardForce up 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"390e49c51d867f1523393defb4d8fab8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SERV","RR","ARBE","GFAI","LFWD","PDYN","STXS","MBOT","SYM","IRBT","KITT"],"gpt_icon":0},{"id":"2565681810","title":"Lifeward Ltd. Secures CE Mark Approval for ReWalk 7 Personal Exoskeleton, Paving Way for European Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2565681810","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565681810?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:31","pubTimestamp":1757334708,"startTime":"0","endTime":"0","summary":"Lifeward Ltd., a leader in medical technology, has achieved CE mark approval for its ReWalk 7 Personal Exoskeleton, allowing for its commercial launch in the European Union. This milestone enables Lifeward to expand its presence in Europe, where 40% of its exoskeleton sales occur, primarily through its German subsidiary, Lifeward GmbH. The ReWalk 7 features innovations like cloud connectivity and customizable walking speeds, enhancing mobility for individuals with spinal cord injuries. With established reimbursement processes in Germany, Lifeward is poised for significant commercial growth in Europe and plans to replicate this successful model in other markets, including the United States.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL7qjnnT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0314104364.USD","BK4604","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4585","BK4588","LU2095319765.USD","LU2210150020.SGD","BK4082","LFWD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://golifeward.com","stockEarnings":[{"period":"1week","weight":0.0316},{"period":"1month","weight":0.0545},{"period":"3month","weight":-0.077},{"period":"6month","weight":-0.1023},{"period":"1year","weight":-0.5511},{"period":"ytd","weight":0.1367}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.045},{"period":"6month","weight":0.1},{"period":"1year","weight":0.1858},{"period":"ytd","weight":0.0124}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.099077},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.048508},{"month":3,"riseRate":0.090909,"avgChangeRate":-0.123184},{"month":4,"riseRate":0.090909,"avgChangeRate":0.011195},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.035343},{"month":6,"riseRate":0.272727,"avgChangeRate":0.002189},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.030658},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.075308},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.017608},{"month":10,"riseRate":0.25,"avgChangeRate":-0.11045},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.100673},{"month":12,"riseRate":0.25,"avgChangeRate":-0.017045}],"exchange":"NASDAQ","name":"Lifeward Ltd","nameEN":"Lifeward Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lifeward Ltd(LFWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Lifeward Ltd(LFWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Lifeward Ltd,LFWD,Lifeward Ltd股票,Lifeward Ltd股票老虎,Lifeward Ltd股票老虎国际,Lifeward Ltd行情,Lifeward Ltd股票行情,Lifeward Ltd股价,Lifeward Ltd股市,Lifeward Ltd股票价格,Lifeward Ltd股票交易,Lifeward Ltd股票购买,Lifeward Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lifeward Ltd(LFWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Lifeward Ltd(LFWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}